International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,043
Self-citationKeating, M. J., O’Brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.051 · Cited by 950
Byrd, J. C. (2003) · Blood · doi:10.1182/blood-2002-04-1258 · Cited by 571
Self-citationWierda, W., O’Brien, S., Wen, S., Faderl, S., Garcia-Manero, G., Thomas, D., Do, K.-A., Cortes, J., Koller, C., Beran, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.516 · Cited by 524
Moreton, P., Kennedy, B., Lucas, G., Leach, M., Rassam, S. M. B., Haynes, A., Tighe, J., Oscier, D., Fegan, C., Rawstron, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.021 · Cited by 419
Self-citationRawstron, A. C., Kennedy, B., Evans, P. A. S., Davies, F. E., Richards, S. J., Haynes, A. P., Russell, N. H., Hale, G., Morgan, G. J., Jack, A. S., et al. (2001) · Blood · doi:10.1182/blood.v98.1.29 · Cited by 269
Self-citationSchulz, H. (2002) · Blood · doi:10.1182/blood-2002-03-0972 · Cited by 204
Kennedy, B., Rawstron, A., Carter, C., Ryan, M., Speed, K., Lucas, G., & Hillmen, P. (2002) · Blood · doi:10.1182/blood.v99.6.2245 · Cited by 186
Self-citationBosch, F., Ferrer, A., López‐Guillermo, A., Giné, E., Bellosillo, B., Villamor, N., Colomer, D., Cobo, F., Perales, M., Esteve, J., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03959.x · Cited by 181
Self-citationRitgen, M., Stilgenbauer, S., von Neuhoff, N., Humpe, A., Brüggemann, M., Pott, C., Raff, T., Kröber, A., Bunjes, D., Schlenk, R., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4321 · Cited by 170
Self-citationTransient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia
Jilani, I. B., O'Brien, S. M., Manshuri, T., Thomas, D. A., Thomázy, V. A., Imam, M., Naeem, S., Verstovšek, S., Kantarjian, H. M., Giles, F. J., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0055 · Cited by 136
Böttcher, S., Ritgen, M., Pott, C., Brüggemann, M., Raff, T., Stilgenbauer, S., Döhner, H., Dreger, P., & Kneba, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403478 · Cited by 99
Self-citationA new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells
Cragg, M. S., Bayne, M., Tutt, A. L., French, R. R., Beers, S. A., Glennie, M. J., & Illidge, T. (2004) · Blood · doi:10.1182/blood-2004-05-1733 · Cited by 47
Thiéblemont, C., Bouafia, F., Hornez, E., Dumontet, C., Tartas, S., Antal, D., Lemieux, B., Traullé, C., Espinouse, D., Salles, G. A., et al. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001615675 · Cited by 32
Maloum, K., Sutton, L., Baudet, S., Laurent, C., Bonnemye, P., Magnac, C., & Merle‐Béral, H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03956.x · Cited by 27
Apparent modulation of CD20 by rituximab: an alternative explanation
Cragg, M. S., Bayne, M. C., Illidge, T., Valerius, T., Johnson, P., & Glennie, M. J. (2004) · Blood · doi:10.1182/blood-2003-12-4384 · Cited by 24
Cited by
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
Self-citationHallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M., Montserrat, E., Chiorazzi, N., et al. (2018) · Blood · doi:10.1182/blood-2017-09-806398 · Cited by 1,740
Self-citationObinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Goede, V., Fischer, K., Busch, R., Engelke, A., Eichhorst, B., Wendtner, C. M., Chagorova, T., de la Serna, J., Dilhuydy, M.-S., Illmer, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313984 · Cited by 1,518
Self-citationon behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Self-citationVenetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
Fischer, K., Al-Sawaf, O., Bahlo, J., Fink, A.-M., Tandon, M., Dixon, M., Robrecht, S., Warburton, S., Humphrey, K., Samoylova, O., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815281 · Cited by 873
Self-citation
Metadata
- Authors
- Rawstron, A. C., Villamor, N., Ritgen, M., Böttcher, S., Ghia, P., Zehnder, J. L., Lozanski, G., Colomer, D., Moreno, C., Geuna, M., Evans, P. A. S., Natkunam, Y., Coutre, S. E., Avery, E. D., Rassenti, L. Z., Kipps, T. J., Caligaris-Cappio, F., Kneba, M., Byrd, J. C., Hallek, M. J., Montserrat, E., & Hillmen, P.
- Venue
- Leukemia
- Published
- 2007-03-15
- Volume
- 21
- Issue
- 5
- Pages
- 956-964
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2156824251
- Cited by
- 403
- References
- 16
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.